We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Bio-Rad Introduces System to Automate Operation of Real-Time PCR Instruments


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Bio-Rad Introduces System to Automate Operation of Real-Time PCR Instruments"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of its CFX Automation System II, a robotic plate handler that enables high-throughput, walk-away real-time PCR automation for all Bio-RadCFX Real-Time PCR Detection Systems.

The new system is ideally suited to meet the high-throughput real-time PCR requirements of today’s drug discovery and screening workflows by facilitating hands-off, around-the-clock data generation and analysis.

The CFX Automation System II can be integrated with one or two CFX Systems while maintaining a small footprint, and includes easy-to-use software that makes automation accessible to all researchers. It is easily integrated with laboratory information management systems (LIMS) to facilitate sample tracking, save time, and minimize human error.

The CFX Automation System II allows laboratories to:
•    Save valuable lab space — operate two CFX Systems with a single plate handler using a fraction of the space required by other systems
•    Meet changing throughput demands — begin with one real-time system and scale up to two systems when required
•    Have confidence in your results — software allows for easy integration of wet-lab validated PrimePCR™ Assays(available in the U.S., Canada, Australia, New Zealand, Singapore, and E.U. only).

Advertisement